Acupuncture for moderate-to-severe seasonal allergy rhinitis
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This trial tests whether acupuncture at a specific spot behind the nose can reduce symptoms from seasonal allergies (triggered by things like grass or birch pollen). It may help if your allergy symptoms are moderate to severe and have lasted for a long time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 75 years old
- You have moderate-to-severe seasonal allergy symptoms most days for at least 4 weeks
- You’ve tested positive for grass and/or birch pollen allergy on skin testing or blood IgE testing
- You can complete study forms and sign consent
- You have not used certain allergy medicines in the past month (like antihistamines, steroid sprays/pills, decongestants, or antibiotics)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new nasal spray designed to relieve the stuffy nose, sneezing, and itching caused by seasonal allergies. It is for people with moderate to severe symptoms that aren’t controlled by other treatments.
This study tests an investigational drug called AK139 to see if it can better control seasonal allergic rhinitis (hay fever) symptoms like sneezing and runny nose. If your symptoms are not well managed with current allergy medicines, this trial might offer a new option.
This study tests a new injection called MG-K10 for people with moderate-to-severe seasonal hay fever that isn't well controlled by standard treatments like nasal sprays or antihistamines. The goal is to see if it can reduce your allergy symptoms over the pollen season.
This trial tests a new injection called SHR-1819 for people with seasonal allergies who haven't responded well to standard treatments like nasal sprays or antihistamines. It aims to see if it can reduce allergy symptoms.
This study tests an investigational injection called TQH2722 combined with standard allergy therapy for seasonal allergic rhinitis (hay fever). It may help people whose allergy symptoms are not well controlled during pollen season.
This trial tests a new biologic medicine (injection) to see if it can better control seasonal allergy symptoms in teens who haven't had good relief from standard treatments like nasal sprays.
Hear when a new Seasonal Allergic Rhinitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.